Form 4 for ATEX Anterix Inc.
Accepted 2024-01-04 00:00:00 ET · period of report 2024-01-02 · accession 0001304492-24-000012 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-04 | 2024-01-02 | ATEX | Kuhn Thomas R. | Dir, Vice COB | A - Grant | $0.00 | +3,898 | 3,898 | New | $0 |
| D | 2024-01-04 | 2024-01-02 | ATEX | Kuhn Thomas R. | Dir, Vice COB | A - Grant | $0.00 | +59.0K | 59.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-02 | A | A | 3,898 | $0.00 | 3,898 | D | — | — | (F1) The restricted stock vests in full on August 7, 2024. |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-01-02 | A | A | 58,998 | $0.00 | 58,998 | D | $33.62 · — to 2034-01-02 | 58,998 Common Stock | (F2) Options awarded in connection with director's appointment to the Board as Vice Chairman. For further information see the Anterix Inc. Form 8-K filed with the Securities Exchange Commission on January 4, 2024. (F3) 1/3rd of the option shares vest and become exercisable on January 2, 2025, with the remaining option shares vesting in 2 equal annual installments thereafter. |